I'm aware.Including using Dogs.My point was that a Phase 1 trial...

First 5 Last

Share
Profile

Follow
Hawk70

1,793 Posts.

568

06/08/24

15:17

Post #: 75093985
Share

Originally posted by ainsleym: ↑

Rather a derogatory posting. From little acorns big oak trees grow. They are proceeding in a logical manner and you start small. They know what they are doing, indeed the MD/CEO? was on the Neuren team when it was 10c on a good day and through their logical small start, methodical approach that stock went to $10+.
Whilst we are doing the GLP preliminary work The US Army Walter Reed Centre is undergoing testwork as well and we should get a readout before too long, And yes, WR use rat(s) as well. WR is the LEADING brain injury research Centre in the USA. A positive result from their prelim work will hold us in good stead for FDA approval to go to Phase 1/2. After all, who would disagree with the US Army ! As for funding, an all clear from WR and no GLP issues would I expectasily funding from the US Army and/ or other agencies in the USA. The US Army has said Traumatic Brain Injury is their Number 1 issue when it comes to medical research. The risk/reward scenarion here is too compelling to ignore.

Expand

I'm aware.

Including using Dogs.

My point was that a Phase 1 trial costs twice as much as you have in the bank.

How are you going to fund it without a CR or JV.

This ain't downramping - it's a question y'all should be asking the board about asap.

Nyrada does have potential.

I agree.

I just don't see how they move forward and stay intact as a company.

NYR Price at posting: 4.2¢ Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

MEM

Many are concerned about global falling birthrates. This diverse stock has solutions

RCE

Recce locks in $30M to boost commercialisation across ASEAN region

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 23.5¢		Change 0.035(17.5%)		Mkt cap ! $49.56M

Open	High	Low	Value	Volume
20.0¢	23.5¢	20.0¢	$405.2K	1.907M

Buyers (Bids)

No.	Vol.	Price($)
2	31257	23.5¢

Sellers (Offers)

Price($)	Vol.	No.
24.0¢	103993	4

View Market Depth

No.	Vol.	Price($)
2	31257	0.235
1	2644	0.225
2	157237	0.215
1	70000	0.210
2	100000	0.205

Price($)	Vol.	No.
0.240	103993	4
0.245	3000	1
0.250	148059	3
0.260	21276	1
0.275	50000	1

Last trade - 16.10pm 17/06/2025 (20 minute delay)

NYR (ASX) Chart

I'm aware.Including using Dogs.My point was that a Phase 1 trial...

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Many are concerned about global falling birthrates. This diverse stock has solutions

Recce locks in $30M to boost commercialisation across ASEAN region

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I'm aware.Including using Dogs.My point was that a Phase 1 trial...

Top Stories

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Many are concerned about global falling birthrates. This diverse stock has solutions

Recce locks in $30M to boost commercialisation across ASEAN region

ASX Market Close: Bourse spins in circles as Israel-Iran conflict weighs | June 17, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News